Moneycontrol PRO
HomeNewsBusinessMarketsPVR INOX, Prime Focus decline up to 5% as Trump to impose 100% tariffs on films made outside US

PVR INOX, Prime Focus decline up to 5% as Trump to impose 100% tariffs on films made outside US

Trump had first floated the tariff threat on non-US made movies in May. However, no timeline has been given for its implementation yet.

September 30, 2025 / 12:01 IST
The announcement comes close on the heels of fresh tariffs imposed by the Trump administration on pharmaceutical products.
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Shares of media and entertainment companies declined on Tuesday after US President Donald Trump announced a 100 percent tariff on movies made outside the United States.

    "Our movie-making business has been stolen from the United States of America, by other Countries, just like stealing ‘candy from a baby’," Trump posted on Truth Social on Monday. "To solve this long time, never ending problem, I will be imposing a 100 percent Tariff on any and all movies that are made outside of the United States," he added.

    The move is expected to impact the Indian film industry, which exports films in multiple languages to the US, where they enjoy significant popularity among the diaspora.

    The Nifty Media index fell over 1 percent, with seven of its 10 constituents trading in the red.

    Prime Focus was the top loser, slipping 5 percent to hit the lower circuit at Rs 175.94 on the NSE. PVR INOX dropped up to 3 percent to Rs 1,072.1, while Mukta Arts declined nearly 2 percent to Rs 68.

    Trump had first floated the tariff threat in May. However, no timeline has been given for its implementation.

    Analysts said it remains unclear how such tariffs would be enforced, given that movies and television shows are also distributed digitally. Questions also remain on how the measure would apply to US films shot in foreign locations.

    The announcement comes close on the heels of fresh tariffs imposed by the Trump administration on pharmaceutical products.

    Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

    Paras Bisht
    Paras Bisht A financial journalist with over 10 years of experience, specialising in tracking stock market movements and fundamental developments that impact investors and the broader economy. A keen observer of global financial markets, I regularly engage with leading market voices to write stories. At Moneycontrol, I focus on decoding market trends, policy shifts and economic changes, driven by a constant passion to learn, analyse, and share knowledge with my readers.
    first published: Sep 30, 2025 11:09 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347